4//SEC Filing
Wells David R. 4
Accession 0001209191-20-024213
CIK 0001681682other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 4:39 PM ET
Size
5.9 KB
Accession
0001209191-20-024213
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Award
Common Stock
2020-04-09+79,653→ 99,653 total
Holdings
- 24,786(indirect: By StoryCorp Consulting)
Common Stock
Footnotes (2)
- [F1]Represents restricted stock units granted in lieu of a portion of the Reporting Person's cash salary. Subject to continued employment, the restricted stock units vest each day, pro rata based on the number of days between the grant date and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes unvested restricted stock units.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001480371
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 4:39 PM ET
- Size
- 5.9 KB